참고문헌
- Barusrux S, Nanok C, Puthisawas W, et al (2012). Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand. Asian Pac J Cancer Prev, 13, 83-7.
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
- Blechacz BR, Gores GJ (2008). Cholangiocarcinoma. Clin Liver Dis, 12, 131-50, ix. https://doi.org/10.1016/j.cld.2007.11.003
- Chang JS, Tsai CR, Chen LT (2013). Medical risk factors associated with cholangiocarcinoma in taiwan: a populationbased case-control study. PLoS One, 8, e69981. https://doi.org/10.1371/journal.pone.0069981
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- El-Serag HB, Engels EA, Landgren O, et al (2009). Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology, 49, 116-23. https://doi.org/10.1002/hep.22606
- Erichsen R, Jepsen P, Vilstrup H, et al (2009). Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003. Eur J Epidemiol, 24, 513-20. https://doi.org/10.1007/s10654-009-9365-4
- Gatto M, Bragazzi MC, Semeraro R, et al (2010). Cholangiocarcinoma: update and future perspectives. Dig Liver Dis, 42, 253-60. https://doi.org/10.1016/j.dld.2009.12.008
- Hamling J, Lee P, Weitkunat R, Ambuhl M (2008). Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med, 27, 954-70. https://doi.org/10.1002/sim.3013
- Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
- Hussain SM, Al-Jashamy KA (2013). Determination of chemical composition of gallbladder stones and their association with induction of cholangiocarcinoma. Asian Pac J Cancer Prev, 14, 6257-60. https://doi.org/10.7314/APJCP.2013.14.11.6257
- Jacobsen BA, Fallingborg J, Rasmussen HH, et al (2006). Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol, 18, 601-6. https://doi.org/10.1097/00042737-200606000-00005
- Jess T, Gamborg M, Matzen P, et al (2005). Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol, 100, 2724-9. https://doi.org/10.1111/j.1572-0241.2005.00287.x
- Jess T, Rungoe C, Peyrin-Biroulet L (2012). Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol, 10, 639-45. https://doi.org/10.1016/j.cgh.2012.01.010
- Lazaridis KN, Gores GJ (2005). Cholangiocarcinoma. Gastroenterology, 128, 1655-67. https://doi.org/10.1053/j.gastro.2005.03.040
- Loftus EV, Jr., Harewood GC, Loftus CG, et al (2005). PSC-IBD:a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut, 54, 91-6. https://doi.org/10.1136/gut.2004.046615
- Luciani MG, Campregher C, Fortune JM, et al (2007). 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint. Gastroenterology, 132, 221-35. https://doi.org/10.1053/j.gastro.2006.10.016
- Manwong M, Songserm N, Promthet S, et al (2013). Risk factors for cholangiocarcinoma in the lower part of northeast Thailand: a hospital-based case-control study. Asian Pac J Cancer Prev, 14, 5953-6. https://doi.org/10.7314/APJCP.2013.14.10.5953
- O’Toole A, Alakkari A, Keegan D, et al (2012). Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol, 10, 439-41. https://doi.org/10.1016/j.cgh.2011.11.010
- Palmer WC, Patel T (2012). Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol, 57, 69-76. https://doi.org/10.1016/j.jhep.2012.02.022
- Patel T (2006). Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3, 33-42. https://doi.org/10.1038/ncpgasthep0389
- Patel T (2011). Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol, 8, 189-200. https://doi.org/10.1038/nrgastro.2011.20
- Pedersen N, Duricova D, Elkjaer M, et al (2010). Risk of extra-intestinal cancer in inflammatory bowel disease:meta-analysis of population-based cohort studies. Am J Gastroenterol, 105, 1480-7. https://doi.org/10.1038/ajg.2009.760
- Saich R, Chapman R (2008). Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol, 14, 331-7. https://doi.org/10.3748/wjg.14.331
- Shaib Y, El-Serag HB (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, 115-25. https://doi.org/10.1055/s-2004-828889
- Shaib YH, El-Serag HB, Davila JA, et al (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 128, 620-6. https://doi.org/10.1053/j.gastro.2004.12.048
- Shivananda S, Lennard-Jones J, Logan R, et al (1996). Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (ECIBD). Gut, 39, 690-7. https://doi.org/10.1136/gut.39.5.690
- Songserm N, Promthet S, Wiangnon S, et al (2012). Prevalence and co-infection of intestinal parasites among Thai rural residents at high-risk of developing cholangiocarcinoma:a cross-sectional study in a prospective cohort study. Asian Pac J Cancer Prev, 13, 6175-9. https://doi.org/10.7314/APJCP.2012.13.12.6175
- Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56. https://doi.org/10.1097/MOG.0b013e3282fbf9b3
- Srivatanakul P, Honjo S, Kittiwatanachot P, et al (2010). Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pac J Cancer Prev, 11, 985-8.
- Tyson GL, El-Serag HB (2011). Risk factors for cholangiocarcinoma. Hepatology, 54, 173-84.
- Vind I, Riis L, Jess T, et al (2006). Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a populationbased study from the Danish Crohn colitis database. Am J Gastroenterol, 101, 1274-82. https://doi.org/10.1111/j.1572-0241.2006.00552.x
- Wells G, Shea B, O'connell D, et al (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
- Welzel TM, Graubard BI, El-Serag HB, et al (2006). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8.
- Welzel TM, Mellemkjaer L, Gloria G, et al (2007). Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer, 120, 638-41. https://doi.org/10.1002/ijc.22283
피인용 문헌
- An Interleukin-6 Receptor Polymorphism is Associated with Opisthorchiasis-Linked Cholangiocarcinoma Risk in Thailand vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5443
- Histopathological Profile of Benign Colorectal Diseases in Al-Madinah Region of Saudi Arabia vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7673
- Novel Mutations in Cholangiocarcinoma with Low Frequencies Revealed by Whole Mitochondrial Genome Sequencing vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1737
- The Carcinogenic Liver Fluke Opisthorchis viverrini is a Reservoir for Species of Helicobacter vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1751
- Expression of Lamininγ2 in Extrahepatic Cholangiocarcinoma Tissues and its Influence on Tumor Invasion and Metastasis vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2099
- Piperine Suppresses the Expression of CXCL8 in Lipopolysaccharide-Activated SW480 and HT-29 Cells via Downregulating the Mitogen-Activated Protein Kinase Pathways vol.38, pp.3, 2015, https://doi.org/10.1007/s10753-014-0075-z
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease vol.15, pp.3, 2017, https://doi.org/10.5217/ir.2017.15.3.266
- Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults pp.00207136, 2018, https://doi.org/10.1002/ijc.31835
- Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis vol.16, pp.1, 2018, https://doi.org/10.1186/s12957-018-1485-4